These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26903446)

  • 1. Kappa Opioids, Salvinorin A and Major Depressive Disorder.
    Taylor GT; Manzella F
    Curr Neuropharmacol; 2016; 14(2):165-76. PubMed ID: 26903446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
    Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
    J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.
    Carlezon WA; Béguin C; DiNieri JA; Baumann MH; Richards MR; Todtenkopf MS; Rothman RB; Ma Z; Lee DY; Cohen BM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):440-7. PubMed ID: 16223871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.
    Yan F; Roth BL
    Life Sci; 2004 Oct; 75(22):2615-9. PubMed ID: 15369697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.
    Kivell BM; Ewald AW; Prisinzano TE
    Adv Pharmacol; 2014; 69():481-511. PubMed ID: 24484985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder.
    Browne CA; Wulf H; Lucki I
    Handb Exp Pharmacol; 2022; 271():493-524. PubMed ID: 33580854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.
    Butelman ER; Yuferov V; Kreek MJ
    Trends Neurosci; 2012 Oct; 35(10):587-96. PubMed ID: 22709632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
    Bruchas MR; Land BB; Chavkin C
    Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.
    Jamensky NT; Gianoulakis C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1455-64. PubMed ID: 9394118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.
    Chartoff EH; Potter D; Damez-Werno D; Cohen BM; Carlezon WA
    Neuropsychopharmacology; 2008 Oct; 33(11):2676-87. PubMed ID: 18185499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
    Carlezon WA; Krystal AD
    Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
    Kivell BM; Paton KF; Kumar N; Morani AS; Culverhouse A; Shepherd A; Welsh SA; Biggerstaff A; Crowley RS; Prisinzano TE
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
    Tejeda HA; Shippenberg TS; Henriksson R
    Cell Mol Life Sci; 2012 Mar; 69(6):857-96. PubMed ID: 22002579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In major depression, increased kappa and mu opioid receptor levels are associated with immune activation.
    Al-Hakeim HK; Zeki Al-Fadhel S; Al-Dujaili AH; Maes M
    Acta Neuropsychiatr; 2020 Apr; 32(2):99-108. PubMed ID: 31753054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
    Pugh G; Smith PB; Dombrowski DS; Welch SP
    J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.